SEC Form 4 · accession 0001144204-15-000645
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian A Markison
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 9:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1,F2 | $1.81 | Dec 31, 2014 | A | 12,241 | A | Dec 31, 2014 | Dec 31, 2024 | Common Stock | 12,241 | 12,241 | D |
Explanation of responses
- F1The stock options have been granted to the Reporting Person for service on the Issuer's Board of Directors and applicable committees for the quarter ended December 31, 2014 in lieu of $13,000 in cash.
- F2On December 31, 2014, the date of grant, the NYSE MKT closing price for the Issuer's common stock was $1.81 per share.